Reports

Industry Research Reports

Global Lentiviral Vector Production System Market Research Report 2026

Global Lentiviral Vector Production System Market Research Report 2026

Industry: Medical Care

Published Date: 2026-05-29

Pages: 166 Pages

Report ld: 5918429

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Lentiviral Vector Production System Market Size(US$)

den_QYR1
cagr

CAGR 2026-2032

11.3%

marketSize

Market Size,2032

USD 2,623

Million

Market Snapshot

Market Size in 2026 (Value)
US$ 1,384 million
Market Forecast in 2032(Value)
US$ 2,623 million
CAGR
11.3%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Lentiviral Vector Production System market was valued at US$ 1252 million in 2025 and is anticipated to reach US$ 2623 million by 2032, at a CAGR of 11.3% from 2026 to 2032.

Lentiviral Vector Production System refers to an integrated set of cell culture, transfection or producer cell line, vector plasmid, packaging, envelope, harvest, purification and quality control processes used to generate lentiviral vector particles for gene delivery, cell therapy, gene therapy research and biomanufacturing applications. The system typically relies on producer cells, commonly HEK293 or HEK293T derived cells, that supply the necessary viral packaging functions while carrying the target genetic payload in a transfer vector, enabling production of replication deficient lentiviral particles that can efficiently deliver genetic material into target cells.

The Lentiviral Vector Production System market is shifting from research-scale vector preparation toward clinical-grade and commercial manufacturing. Demand is mainly driven by cell therapy, gene therapy and functional genomics applications. As gene-modified cell therapy programs continue to advance, customers increasingly require high-titer, high-purity, low-residual, scalable and GMP-compliant production systems. This is driving the market from standalone transfection or packaging reagents toward end-to-end process platforms covering cell culture, plasmid supply, viral packaging, harvest and clarification, purification and concentration, and quality control. Future competition will focus on production efficiency, batch-to-batch consistency, closed and automated processing, regulatory compliance, and process transferability from research-grade to clinical-grade manufacturing.

This report delivers a comprehensive overview of the global Lentiviral Vector Production System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Lentiviral Vector Production System. The Lentiviral Vector Production System market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Lentiviral Vector Production System market comprehensively. Regional market sizes by Type, by Application, by Technical Route, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Lentiviral Vector Production System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

By Company

  • Thermo Fisher Scientific
  • Lonza
  • Charles River
  • Merck
  • Cytiva
  • OXB
  • AGC Biologics
  • OriGene
  • Sartorius
  • OmniaBio
  • SignaGen Laboratories
  • Cellomics Technology
  • Miltenyi Bioindustry
  • Gene Universal
  • Takara Bio
  • Gentarget
  • Genezen
  • Creative Biogene
  • VIVEbiotech
  • SK pharmteco
  • Esco Aster
  • Andelyn Biosciences
  • GENEWIZ
  • GenScript ProBio
  • VectorBuilder
  • OBiO Tech
  • GenePharma
  • GeneMedi
  • Genevoyager
  • FulenGen

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Production Workflow Products
  • GMP Manufacturing Services
  • Research-grade Packaging Services

Segment by Application

  • Cell Therapy
  • Gene Therapy
  • Basic Research
  • Others

Segment by Category

  • Transient Transfection
  • Stable Cell Line

Segment by Division

  • Adherent Production
  • Suspension Production

biaoTi Chapter Outline

marn_i1

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Technical Route, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

marn_i1

Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.

marn_i1

Chapter 3: Provides a detailed view of the competitive landscape for Lentiviral Vector Production System companies, covering revenue share, development plans, and mergers and acquisitions.

marn_i1

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.

marn_i1

Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

marn_i1

Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.

marn_i1

Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.

marn_i1

Chapter 12: Key findings and conclusions of the report.

biaoTi QYResearch's Strengths

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

Table of Contents

muLu

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Lentiviral Vector Production System Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Production Workflow Products

1.2.3 GMP Manufacturing Services

1.2.4 Research-grade Packaging Services

1.3 Market by Technical Route

1.3.1 Global Lentiviral Vector Production System Market Size Growth Rate by Technical Route: 2021 vs 2025 vs 2032

1.3.2 Transient Transfection

1.3.3 Stable Cell Line

1.4 Market by Cell Culture Mode

1.4.1 Global Lentiviral Vector Production System Market Size Growth Rate by Cell Culture Mode: 2021 vs 2025 vs 2032

1.4.2 Adherent Production

1.4.3 Suspension Production

1.5 Market by Application

1.5.1 Global Lentiviral Vector Production System Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Cell Therapy

1.5.3 Gene Therapy

1.5.4 Basic Research

1.5.5 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

muLu

2 Global Growth Trends

2.1 Global Lentiviral Vector Production System Market Perspective (2021–2032)

2.2 Global Lentiviral Vector Production System Growth Trends by Region

2.2.1 Global Lentiviral Vector Production System Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Lentiviral Vector Production System Historic Market Size by Region (2021–2026)

2.2.3 Lentiviral Vector Production System Forecasted Market Size by Region (2027–2032)

2.3 Lentiviral Vector Production System Market Dynamics

2.3.1 Lentiviral Vector Production System Industry Trends

2.3.2 Lentiviral Vector Production System Market Drivers

2.3.3 Lentiviral Vector Production System Market Challenges

2.3.4 Lentiviral Vector Production System Market Restraints

muLu

3 Competition Landscape by Key Players

3.1 Global Top Lentiviral Vector Production System Players by Revenue

3.1.1 Global Top Lentiviral Vector Production System Players by Revenue (2021–2026)

3.1.2 Global Lentiviral Vector Production System Revenue Market Share by Players (2021–2026)

3.2 Global Top Lentiviral Vector Production System Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Lentiviral Vector Production System Revenue

3.4 Global Lentiviral Vector Production System Market Concentration Ratio

3.4.1 Global Lentiviral Vector Production System Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Lentiviral Vector Production System Revenue in 2025

3.5 Global Key Players of Lentiviral Vector Production System Head Offices and Areas Served

3.6 Global Key Players of Lentiviral Vector Production System, Products and Applications

3.7 Global Key Players of Lentiviral Vector Production System, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

muLu

4 Lentiviral Vector Production System Breakdown Data by Type

4.1 Global Lentiviral Vector Production System Historic Market Size by Type (2021–2026)

4.2 Global Lentiviral Vector Production System Forecasted Market Size by Type (2027–2032)

muLu

5 Lentiviral Vector Production System Breakdown Data by Application

5.1 Global Lentiviral Vector Production System Historic Market Size by Application (2021–2026)

5.2 Global Lentiviral Vector Production System Forecasted Market Size by Application (2027–2032)

muLu

6 North America

6.1 North America Lentiviral Vector Production System Market Size (2021–2032)

6.2 North America Lentiviral Vector Production System Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Lentiviral Vector Production System Market Size by Country (2021–2026)

6.4 North America Lentiviral Vector Production System Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

muLu

7 Europe

7.1 Europe Lentiviral Vector Production System Market Size (2021–2032)

7.2 Europe Lentiviral Vector Production System Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Lentiviral Vector Production System Market Size by Country (2021–2026)

7.4 Europe Lentiviral Vector Production System Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

muLu

8 Asia-Pacific

8.1 Asia-Pacific Lentiviral Vector Production System Market Size (2021–2032)

8.2 Asia-Pacific Lentiviral Vector Production System Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Lentiviral Vector Production System Market Size by Region (2021–2026)

8.4 Asia-Pacific Lentiviral Vector Production System Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

muLu

9 Latin America

9.1 Latin America Lentiviral Vector Production System Market Size (2021–2032)

9.2 Latin America Lentiviral Vector Production System Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Lentiviral Vector Production System Market Size by Country (2021–2026)

9.4 Latin America Lentiviral Vector Production System Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

muLu

10 Middle East & Africa

10.1 Middle East & Africa Lentiviral Vector Production System Market Size (2021–2032)

10.2 Middle East & Africa Lentiviral Vector Production System Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Lentiviral Vector Production System Market Size by Country (2021–2026)

10.4 Middle East & Africa Lentiviral Vector Production System Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

muLu

11 Key Players Profiles

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Details

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific Lentiviral Vector Production System Introduction

11.1.4 Thermo Fisher Scientific Revenue in Lentiviral Vector Production System Business (2021–2026)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 Lonza

11.2.1 Lonza Company Details

11.2.2 Lonza Business Overview

11.2.3 Lonza Lentiviral Vector Production System Introduction

11.2.4 Lonza Revenue in Lentiviral Vector Production System Business (2021–2026)

11.2.5 Lonza Recent Development

11.3 Charles River

11.3.1 Charles River Company Details

11.3.2 Charles River Business Overview

11.3.3 Charles River Lentiviral Vector Production System Introduction

11.3.4 Charles River Revenue in Lentiviral Vector Production System Business (2021–2026)

11.3.5 Charles River Recent Development

11.4 Merck

11.4.1 Merck Company Details

11.4.2 Merck Business Overview

11.4.3 Merck Lentiviral Vector Production System Introduction

11.4.4 Merck Revenue in Lentiviral Vector Production System Business (2021–2026)

11.4.5 Merck Recent Development

11.5 Cytiva

11.5.1 Cytiva Company Details

11.5.2 Cytiva Business Overview

11.5.3 Cytiva Lentiviral Vector Production System Introduction

11.5.4 Cytiva Revenue in Lentiviral Vector Production System Business (2021–2026)

11.5.5 Cytiva Recent Development

11.6 OXB

11.6.1 OXB Company Details

11.6.2 OXB Business Overview

11.6.3 OXB Lentiviral Vector Production System Introduction

11.6.4 OXB Revenue in Lentiviral Vector Production System Business (2021–2026)

11.6.5 OXB Recent Development

11.7 AGC Biologics

11.7.1 AGC Biologics Company Details

11.7.2 AGC Biologics Business Overview

11.7.3 AGC Biologics Lentiviral Vector Production System Introduction

11.7.4 AGC Biologics Revenue in Lentiviral Vector Production System Business (2021–2026)

11.7.5 AGC Biologics Recent Development

11.8 OriGene

11.8.1 OriGene Company Details

11.8.2 OriGene Business Overview

11.8.3 OriGene Lentiviral Vector Production System Introduction

11.8.4 OriGene Revenue in Lentiviral Vector Production System Business (2021–2026)

11.8.5 OriGene Recent Development

11.9 Sartorius

11.9.1 Sartorius Company Details

11.9.2 Sartorius Business Overview

11.9.3 Sartorius Lentiviral Vector Production System Introduction

11.9.4 Sartorius Revenue in Lentiviral Vector Production System Business (2021–2026)

11.9.5 Sartorius Recent Development

11.10 OmniaBio

11.10.1 OmniaBio Company Details

11.10.2 OmniaBio Business Overview

11.10.3 OmniaBio Lentiviral Vector Production System Introduction

11.10.4 OmniaBio Revenue in Lentiviral Vector Production System Business (2021–2026)

11.10.5 OmniaBio Recent Development

11.11 SignaGen Laboratories

11.11.1 SignaGen Laboratories Company Details

11.11.2 SignaGen Laboratories Business Overview

11.11.3 SignaGen Laboratories Lentiviral Vector Production System Introduction

11.11.4 SignaGen Laboratories Revenue in Lentiviral Vector Production System Business (2021–2026)

11.11.5 SignaGen Laboratories Recent Development

11.12 Cellomics Technology

11.12.1 Cellomics Technology Company Details

11.12.2 Cellomics Technology Business Overview

11.12.3 Cellomics Technology Lentiviral Vector Production System Introduction

11.12.4 Cellomics Technology Revenue in Lentiviral Vector Production System Business (2021–2026)

11.12.5 Cellomics Technology Recent Development

11.13 Miltenyi Bioindustry

11.13.1 Miltenyi Bioindustry Company Details

11.13.2 Miltenyi Bioindustry Business Overview

11.13.3 Miltenyi Bioindustry Lentiviral Vector Production System Introduction

11.13.4 Miltenyi Bioindustry Revenue in Lentiviral Vector Production System Business (2021–2026)

11.13.5 Miltenyi Bioindustry Recent Development

11.14 Gene Universal

11.14.1 Gene Universal Company Details

11.14.2 Gene Universal Business Overview

11.14.3 Gene Universal Lentiviral Vector Production System Introduction

11.14.4 Gene Universal Revenue in Lentiviral Vector Production System Business (2021–2026)

11.14.5 Gene Universal Recent Development

11.15 Takara Bio

11.15.1 Takara Bio Company Details

11.15.2 Takara Bio Business Overview

11.15.3 Takara Bio Lentiviral Vector Production System Introduction

11.15.4 Takara Bio Revenue in Lentiviral Vector Production System Business (2021–2026)

11.15.5 Takara Bio Recent Development

11.16 Gentarget

11.16.1 Gentarget Company Details

11.16.2 Gentarget Business Overview

11.16.3 Gentarget Lentiviral Vector Production System Introduction

11.16.4 Gentarget Revenue in Lentiviral Vector Production System Business (2021–2026)

11.16.5 Gentarget Recent Development

11.17 Genezen

11.17.1 Genezen Company Details

11.17.2 Genezen Business Overview

11.17.3 Genezen Lentiviral Vector Production System Introduction

11.17.4 Genezen Revenue in Lentiviral Vector Production System Business (2021–2026)

11.17.5 Genezen Recent Development

11.18 Creative Biogene

11.18.1 Creative Biogene Company Details

11.18.2 Creative Biogene Business Overview

11.18.3 Creative Biogene Lentiviral Vector Production System Introduction

11.18.4 Creative Biogene Revenue in Lentiviral Vector Production System Business (2021–2026)

11.18.5 Creative Biogene Recent Development

11.19 VIVEbiotech

11.19.1 VIVEbiotech Company Details

11.19.2 VIVEbiotech Business Overview

11.19.3 VIVEbiotech Lentiviral Vector Production System Introduction

11.19.4 VIVEbiotech Revenue in Lentiviral Vector Production System Business (2021–2026)

11.19.5 VIVEbiotech Recent Development

11.20 SK pharmteco

11.20.1 SK pharmteco Company Details

11.20.2 SK pharmteco Business Overview

11.20.3 SK pharmteco Lentiviral Vector Production System Introduction

11.20.4 SK pharmteco Revenue in Lentiviral Vector Production System Business (2021–2026)

11.20.5 SK pharmteco Recent Development

11.21 Esco Aster

11.21.1 Esco Aster Company Details

11.21.2 Esco Aster Business Overview

11.21.3 Esco Aster Lentiviral Vector Production System Introduction

11.21.4 Esco Aster Revenue in Lentiviral Vector Production System Business (2021–2026)

11.21.5 Esco Aster Recent Development

11.22 Andelyn Biosciences

11.22.1 Andelyn Biosciences Company Details

11.22.2 Andelyn Biosciences Business Overview

11.22.3 Andelyn Biosciences Lentiviral Vector Production System Introduction

11.22.4 Andelyn Biosciences Revenue in Lentiviral Vector Production System Business (2021–2026)

11.22.5 Andelyn Biosciences Recent Development

11.23 GENEWIZ

11.23.1 GENEWIZ Company Details

11.23.2 GENEWIZ Business Overview

11.23.3 GENEWIZ Lentiviral Vector Production System Introduction

11.23.4 GENEWIZ Revenue in Lentiviral Vector Production System Business (2021–2026)

11.23.5 GENEWIZ Recent Development

11.24 GenScript ProBio

11.24.1 GenScript ProBio Company Details

11.24.2 GenScript ProBio Business Overview

11.24.3 GenScript ProBio Lentiviral Vector Production System Introduction

11.24.4 GenScript ProBio Revenue in Lentiviral Vector Production System Business (2021–2026)

11.24.5 GenScript ProBio Recent Development

11.25 VectorBuilder

11.25.1 VectorBuilder Company Details

11.25.2 VectorBuilder Business Overview

11.25.3 VectorBuilder Lentiviral Vector Production System Introduction

11.25.4 VectorBuilder Revenue in Lentiviral Vector Production System Business (2021–2026)

11.25.5 VectorBuilder Recent Development

11.26 OBiO Tech

11.26.1 OBiO Tech Company Details

11.26.2 OBiO Tech Business Overview

11.26.3 OBiO Tech Lentiviral Vector Production System Introduction

11.26.4 OBiO Tech Revenue in Lentiviral Vector Production System Business (2021–2026)

11.26.5 OBiO Tech Recent Development

11.27 GenePharma

11.27.1 GenePharma Company Details

11.27.2 GenePharma Business Overview

11.27.3 GenePharma Lentiviral Vector Production System Introduction

11.27.4 GenePharma Revenue in Lentiviral Vector Production System Business (2021–2026)

11.27.5 GenePharma Recent Development

11.28 GeneMedi

11.28.1 GeneMedi Company Details

11.28.2 GeneMedi Business Overview

11.28.3 GeneMedi Lentiviral Vector Production System Introduction

11.28.4 GeneMedi Revenue in Lentiviral Vector Production System Business (2021–2026)

11.28.5 GeneMedi Recent Development

11.29 Genevoyager

11.29.1 Genevoyager Company Details

11.29.2 Genevoyager Business Overview

11.29.3 Genevoyager Lentiviral Vector Production System Introduction

11.29.4 Genevoyager Revenue in Lentiviral Vector Production System Business (2021–2026)

11.29.5 Genevoyager Recent Development

11.30 FulenGen

11.30.1 FulenGen Company Details

11.30.2 FulenGen Business Overview

11.30.3 FulenGen Lentiviral Vector Production System Introduction

11.30.4 FulenGen Revenue in Lentiviral Vector Production System Business (2021–2026)

11.30.5 FulenGen Recent Development

muLu

12 Analyst's Viewpoints/Conclusions

muLu

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

den_biaoTiZhungShi

Table of Figures

muLu

List of Tables

Table 1. Global Lentiviral Vector Production System Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Production Workflow Products
Table 3. Key Players of GMP Manufacturing Services
Table 4. Key Players of Research-grade Packaging Services
Table 5. Global Lentiviral Vector Production System Market Size Growth Rate by Technical Route (US$ Million): 2021 vs 2025 vs 2032
Table 6. Key Players of Transient Transfection
Table 7. Key Players of Stable Cell Line
Table 8. Global Lentiviral Vector Production System Market Size Growth Rate by Cell Culture Mode (US$ Million): 2021 vs 2025 vs 2032
Table 9. Key Players of Adherent Production
Table 10. Key Players of Suspension Production
Table 11. Global Lentiviral Vector Production System Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 12. Global Lentiviral Vector Production System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 13. Global Lentiviral Vector Production System Market Size by Region (US$ Million), 2021–2026
Table 14. Global Lentiviral Vector Production System Market Share by Region (2021–2026)
Table 15. Global Lentiviral Vector Production System Forecasted Market Size by Region (US$ Million), 2027–2032
Table 16. Global Lentiviral Vector Production System Market Share by Region (2027–2032)
Table 17. Lentiviral Vector Production System Market Trends
Table 18. Lentiviral Vector Production System Market Drivers
Table 19. Lentiviral Vector Production System Market Challenges
Table 20. Lentiviral Vector Production System Market Restraints
Table 21. Global Lentiviral Vector Production System Revenue by Players (US$ Million), 2021–2026
Table 22. Global Lentiviral Vector Production System Market Share by Players (2021–2026)
Table 23. Global Top Lentiviral Vector Production System Players by Tier (Tier 1, Tier 2, and Tier 3), based on Lentiviral Vector Production System Revenue, 2025
Table 24. Ranking of Global Top Lentiviral Vector Production System Companies by Revenue (US$ Million) in 2025
Table 25. Global 5 Largest Players Market Share by Lentiviral Vector Production System Revenue (CR5 and HHI), 2021–2026
Table 26. Global Key Players of Lentiviral Vector Production System, Headquarters and Area Served
Table 27. Global Key Players of Lentiviral Vector Production System, Products and Applications
Table 28. Global Key Players of Lentiviral Vector Production System, Date of General Availability (GA)
Table 29. Mergers and Acquisitions, Expansion Plans
Table 30. Global Lentiviral Vector Production System Market Size by Type (US$ Million), 2021–2026
Table 31. Global Lentiviral Vector Production System Revenue Market Share by Type (2021–2026)
Table 32. Global Lentiviral Vector Production System Forecasted Market Size by Type (US$ Million), 2027–2032
Table 33. Global Lentiviral Vector Production System Revenue Market Share by Type (2027–2032)
Table 34. Global Lentiviral Vector Production System Market Size by Application (US$ Million), 2021–2026
Table 35. Global Lentiviral Vector Production System Revenue Market Share by Application (2021–2026)
Table 36. Global Lentiviral Vector Production System Forecasted Market Size by Application (US$ Million), 2027–2032
Table 37. Global Lentiviral Vector Production System Revenue Market Share by Application (2027–2032)
Table 38. North America Lentiviral Vector Production System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 39. North America Lentiviral Vector Production System Market Size by Country (US$ Million), 2021–2026
Table 40. North America Lentiviral Vector Production System Market Size by Country (US$ Million), 2027–2032
Table 41. Europe Lentiviral Vector Production System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Europe Lentiviral Vector Production System Market Size by Country (US$ Million), 2021–2026
Table 43. Europe Lentiviral Vector Production System Market Size by Country (US$ Million), 2027–2032
Table 44. Asia-Pacific Lentiviral Vector Production System Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 45. Asia-Pacific Lentiviral Vector Production System Market Size by Region (US$ Million), 2021–2026
Table 46. Asia-Pacific Lentiviral Vector Production System Market Size by Region (US$ Million), 2027–2032
Table 47. Latin America Lentiviral Vector Production System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 48. Latin America Lentiviral Vector Production System Market Size by Country (US$ Million), 2021–2026
Table 49. Latin America Lentiviral Vector Production System Market Size by Country (US$ Million), 2027–2032
Table 50. Middle East & Africa Lentiviral Vector Production System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 51. Middle East & Africa Lentiviral Vector Production System Market Size by Country (US$ Million), 2021–2026
Table 52. Middle East & Africa Lentiviral Vector Production System Market Size by Country (US$ Million), 2027–2032
Table 53. Thermo Fisher Scientific Company Details
Table 54. Thermo Fisher Scientific Business Overview
Table 55. Thermo Fisher Scientific Lentiviral Vector Production System Product
Table 56. Thermo Fisher Scientific Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 57. Thermo Fisher Scientific Recent Development
Table 58. Lonza Company Details
Table 59. Lonza Business Overview
Table 60. Lonza Lentiviral Vector Production System Product
Table 61. Lonza Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 62. Lonza Recent Development
Table 63. Charles River Company Details
Table 64. Charles River Business Overview
Table 65. Charles River Lentiviral Vector Production System Product
Table 66. Charles River Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 67. Charles River Recent Development
Table 68. Merck Company Details
Table 69. Merck Business Overview
Table 70. Merck Lentiviral Vector Production System Product
Table 71. Merck Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 72. Merck Recent Development
Table 73. Cytiva Company Details
Table 74. Cytiva Business Overview
Table 75. Cytiva Lentiviral Vector Production System Product
Table 76. Cytiva Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 77. Cytiva Recent Development
Table 78. OXB Company Details
Table 79. OXB Business Overview
Table 80. OXB Lentiviral Vector Production System Product
Table 81. OXB Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 82. OXB Recent Development
Table 83. AGC Biologics Company Details
Table 84. AGC Biologics Business Overview
Table 85. AGC Biologics Lentiviral Vector Production System Product
Table 86. AGC Biologics Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 87. AGC Biologics Recent Development
Table 88. OriGene Company Details
Table 89. OriGene Business Overview
Table 90. OriGene Lentiviral Vector Production System Product
Table 91. OriGene Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 92. OriGene Recent Development
Table 93. Sartorius Company Details
Table 94. Sartorius Business Overview
Table 95. Sartorius Lentiviral Vector Production System Product
Table 96. Sartorius Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 97. Sartorius Recent Development
Table 98. OmniaBio Company Details
Table 99. OmniaBio Business Overview
Table 100. OmniaBio Lentiviral Vector Production System Product
Table 101. OmniaBio Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 102. OmniaBio Recent Development
Table 103. SignaGen Laboratories Company Details
Table 104. SignaGen Laboratories Business Overview
Table 105. SignaGen Laboratories Lentiviral Vector Production System Product
Table 106. SignaGen Laboratories Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 107. SignaGen Laboratories Recent Development
Table 108. Cellomics Technology Company Details
Table 109. Cellomics Technology Business Overview
Table 110. Cellomics Technology Lentiviral Vector Production System Product
Table 111. Cellomics Technology Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 112. Cellomics Technology Recent Development
Table 113. Miltenyi Bioindustry Company Details
Table 114. Miltenyi Bioindustry Business Overview
Table 115. Miltenyi Bioindustry Lentiviral Vector Production System Product
Table 116. Miltenyi Bioindustry Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 117. Miltenyi Bioindustry Recent Development
Table 118. Gene Universal Company Details
Table 119. Gene Universal Business Overview
Table 120. Gene Universal Lentiviral Vector Production System Product
Table 121. Gene Universal Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 122. Gene Universal Recent Development
Table 123. Takara Bio Company Details
Table 124. Takara Bio Business Overview
Table 125. Takara Bio Lentiviral Vector Production System Product
Table 126. Takara Bio Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 127. Takara Bio Recent Development
Table 128. Gentarget Company Details
Table 129. Gentarget Business Overview
Table 130. Gentarget Lentiviral Vector Production System Product
Table 131. Gentarget Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 132. Gentarget Recent Development
Table 133. Genezen Company Details
Table 134. Genezen Business Overview
Table 135. Genezen Lentiviral Vector Production System Product
Table 136. Genezen Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 137. Genezen Recent Development
Table 138. Creative Biogene Company Details
Table 139. Creative Biogene Business Overview
Table 140. Creative Biogene Lentiviral Vector Production System Product
Table 141. Creative Biogene Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 142. Creative Biogene Recent Development
Table 143. VIVEbiotech Company Details
Table 144. VIVEbiotech Business Overview
Table 145. VIVEbiotech Lentiviral Vector Production System Product
Table 146. VIVEbiotech Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 147. VIVEbiotech Recent Development
Table 148. SK pharmteco Company Details
Table 149. SK pharmteco Business Overview
Table 150. SK pharmteco Lentiviral Vector Production System Product
Table 151. SK pharmteco Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 152. SK pharmteco Recent Development
Table 153. Esco Aster Company Details
Table 154. Esco Aster Business Overview
Table 155. Esco Aster Lentiviral Vector Production System Product
Table 156. Esco Aster Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 157. Esco Aster Recent Development
Table 158. Andelyn Biosciences Company Details
Table 159. Andelyn Biosciences Business Overview
Table 160. Andelyn Biosciences Lentiviral Vector Production System Product
Table 161. Andelyn Biosciences Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 162. Andelyn Biosciences Recent Development
Table 163. GENEWIZ Company Details
Table 164. GENEWIZ Business Overview
Table 165. GENEWIZ Lentiviral Vector Production System Product
Table 166. GENEWIZ Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 167. GENEWIZ Recent Development
Table 168. GenScript ProBio Company Details
Table 169. GenScript ProBio Business Overview
Table 170. GenScript ProBio Lentiviral Vector Production System Product
Table 171. GenScript ProBio Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 172. GenScript ProBio Recent Development
Table 173. VectorBuilder Company Details
Table 174. VectorBuilder Business Overview
Table 175. VectorBuilder Lentiviral Vector Production System Product
Table 176. VectorBuilder Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 177. VectorBuilder Recent Development
Table 178. OBiO Tech Company Details
Table 179. OBiO Tech Business Overview
Table 180. OBiO Tech Lentiviral Vector Production System Product
Table 181. OBiO Tech Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 182. OBiO Tech Recent Development
Table 183. GenePharma Company Details
Table 184. GenePharma Business Overview
Table 185. GenePharma Lentiviral Vector Production System Product
Table 186. GenePharma Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 187. GenePharma Recent Development
Table 188. GeneMedi Company Details
Table 189. GeneMedi Business Overview
Table 190. GeneMedi Lentiviral Vector Production System Product
Table 191. GeneMedi Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 192. GeneMedi Recent Development
Table 193. Genevoyager Company Details
Table 194. Genevoyager Business Overview
Table 195. Genevoyager Lentiviral Vector Production System Product
Table 196. Genevoyager Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 197. Genevoyager Recent Development
Table 198. FulenGen Company Details
Table 199. FulenGen Business Overview
Table 200. FulenGen Lentiviral Vector Production System Product
Table 201. FulenGen Revenue in Lentiviral Vector Production System Business (US$ Million), 2021–2026
Table 202. FulenGen Recent Development
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
Table 206. Authors List of This Report
muLu

List of Figures

Figure 1. Lentiviral Vector Production System Picture
Figure 2. Global Lentiviral Vector Production System Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Lentiviral Vector Production System Market Share by Type: 2025 vs 2032
Figure 4. Production Workflow Products Features
Figure 5. GMP Manufacturing Services Features
Figure 6. Research-grade Packaging Services Features
Figure 7. Global Lentiviral Vector Production System Market Size Comparison by Technical Route (US$ Million), 2021–2032
Figure 8. Transient Transfection Features
Figure 9. Stable Cell Line Features
Figure 10. Global Lentiviral Vector Production System Market Size Comparison by Cell Culture Mode (US$ Million), 2021–2032
Figure 11. Adherent Production Features
Figure 12. Suspension Production Features
Figure 13. Global Lentiviral Vector Production System Market Size by Application (US$ Million), 2021–2032
Figure 14. Global Lentiviral Vector Production System Market Share by Application: 2025 vs 2032
Figure 15. Cell Therapy Case Studies
Figure 16. Gene Therapy Case Studies
Figure 17. Basic Research Case Studies
Figure 18. Others Case Studies
Figure 19. Lentiviral Vector Production System Report Years Considered
Figure 20. Global Lentiviral Vector Production System Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 21. Global Lentiviral Vector Production System Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 22. Global Lentiviral Vector Production System Market Share by Region: 2025 vs 2032
Figure 23. Global Lentiviral Vector Production System Market Share by Players in 2025
Figure 24. Global Lentiviral Vector Production System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. The Top 10 and 5 Players Market Share by Lentiviral Vector Production System Revenue in 2025
Figure 26. North America Lentiviral Vector Production System Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. North America Lentiviral Vector Production System Market Share by Country (2021–2032)
Figure 28. United States Lentiviral Vector Production System Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Canada Lentiviral Vector Production System Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Europe Lentiviral Vector Production System Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Europe Lentiviral Vector Production System Market Share by Country (2021–2032)
Figure 32. Germany Lentiviral Vector Production System Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. France Lentiviral Vector Production System Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. U.K. Lentiviral Vector Production System Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Italy Lentiviral Vector Production System Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Russia Lentiviral Vector Production System Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Ireland Lentiviral Vector Production System Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Asia-Pacific Lentiviral Vector Production System Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Asia-Pacific Lentiviral Vector Production System Market Share by Region (2021–2032)
Figure 40. China Lentiviral Vector Production System Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Japan Lentiviral Vector Production System Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. South Korea Lentiviral Vector Production System Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Southeast Asia Lentiviral Vector Production System Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. India Lentiviral Vector Production System Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Australia & New Zealand Lentiviral Vector Production System Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Latin America Lentiviral Vector Production System Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Latin America Lentiviral Vector Production System Market Share by Country (2021–2032)
Figure 48. Mexico Lentiviral Vector Production System Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Brazil Lentiviral Vector Production System Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Middle East & Africa Lentiviral Vector Production System Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Middle East & Africa Lentiviral Vector Production System Market Share by Country (2021–2032)
Figure 52. Israel Lentiviral Vector Production System Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. Saudi Arabia Lentiviral Vector Production System Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. UAE Lentiviral Vector Production System Market Size YoY Growth (US$ Million), 2021–2032
Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 56. Lonza Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 57. Charles River Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 58. Merck Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 59. Cytiva Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 60. OXB Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 61. AGC Biologics Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 62. OriGene Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 63. Sartorius Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 64. OmniaBio Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 65. SignaGen Laboratories Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 66. Cellomics Technology Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 67. Miltenyi Bioindustry Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 68. Gene Universal Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 69. Takara Bio Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 70. Gentarget Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 71. Genezen Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 72. Creative Biogene Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 73. VIVEbiotech Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 74. SK pharmteco Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 75. Esco Aster Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 76. Andelyn Biosciences Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 77. GENEWIZ Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 78. GenScript ProBio Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 79. VectorBuilder Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 80. OBiO Tech Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 81. GenePharma Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 82. GeneMedi Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 83. Genevoyager Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 84. FulenGen Revenue Growth Rate in Lentiviral Vector Production System Business (2021–2026)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
den_biaoTiZhungShi

Related Reports

Global Lentiviral Vector Production System Market Research Report 2026

Industry: Medical Care

Published Date: 2026-05-29

Pages: 166 Pages

Report ld: 5918429

CHOOSE LICENSE TYPE
tip

USD 2900.00

tip

USD 4350.00

tip

USD 5800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English

English

Offline

HITESH

English

English

Offline

TANG XIN

Japanese

Japanese

Offline

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Offline

YUJIE TIAN

English

English

Offline

DAMON

Chinese

Chinese

Offline

General Email:

REPORT COVERAGE

zhankai
den_ic7

Market Segmentation

den_ic7

QYResearch's Strengths

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

Interest In This Report?

Get A Free Sample

Pre-Order Enquiry

OR

Need a Tailored Report?

Customize this report to your needs.

Customize This Report

den_gou

Fact Checked

den_gou

Cite this Research

biaoTi

WORLD WIDE OFFICE